ArticleCell death and differentiation2026
CRISPR/Cas9 library screening uncovered CCT2 as a critical driver of acquired resistance to EGFR-targeted therapy by stabilizing TMX1 in non-small cell lung cancer.
Zihao Ke et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.